Factors affecting patient's perception of anticancer treatments side-effects: An observational study

Expert Opinion on Drug Safety

Volumn 13, Issue 2, 2014, Pages 139-150

  Russo, Stefania ^a   Cinausero, Marika ^a   Gerratana, Lorenzo ^a   Bozza, Claudia ^a   Iacono, Donatella ^a   Driol, Pamela ^b   Deroma, Laura ^a   Sottile, Roberta ^a   Fasola, Gianpiero ^a   Puglisi, Fabio ^a,c  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

^b General Hospital   (Italy)

^c UNIVERSITY OF UDINE   (Italy)

Author keywords

Anticancer therapy; Quality of life; Side effects; Supportive care

Indexed keywords

ANTINEOPLASTIC AGENT;

ABDOMINAL DISTENSION; ABNORMAL URINE COMPOSITION; ACNE; ADULT; ADVERSE DRUG REACTION; ALOPECIA; AMENORRHEA; ARTICLE; CANCER PATIENT; CONSTIPATION; DEPRESSION; DIARRHEA; DIZZINESS; DRY SKIN; DYSPHAGIA; DYSPNEA; DYSURIA; ECCHYMOSIS; EPISTAXIS; ERYTHEMA; FAMILY; FATIGUE; FEMALE; HEADACHE; HEARING IMPAIRMENT; HEART PALPITATION; HOME; HOT FLUSH; HUMAN; IMPOTENCE; INCREASED APPETITE; INFERTILITY; INJECTION SITE PRURITUS; LOSS OF APPETITE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MENSTRUAL IRREGULARITY; MIDDLE AGED; MIGRAINE; MOUTH PAIN; NAIL DISEASE; NAUSEA; OBSERVATIONAL STUDY; PAIN; PARESTHESIA; PATIENT ATTITUDE; PATIENT COUNSELING; PATIENT EDUCATION; POLLAKISURIA; POLYDIPSIA; RASH; SEXUAL DYSFUNCTION; SKIN MANIFESTATION; SKIN TINGLING; SLEEP DISORDER; SMELLING DISORDER; SORE THROAT; STOMACH PAIN; STRESS; TASTE DISORDER; UNSPECIFIED SIDE EFFECT; URTICARIA; VOMITING; WORK CAPACITY; WORK DISABILITY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NAUSEA; PERCEPTION; VOMITING;

EID: 84892696920     PISSN: 14740338     EISSN: 1744764X     Source Type: Journal    
DOI: 10.1517/14740338.2013.830710     Document Type: Article

References (24)

1. Mulders M, Vingerhoets A, Breed W. The impact of cancer and chemotherapy: perceptual similarities and differences between cancer patients, nurses and physicians. Eur J Oncol Nurs 2008;12: 97-102
2. Osoba D. Health-related quality of life and cancer clinical trials. Ther Adv Med Oncol 2011;3: 57-71
3. Cleeland CS, Sloan JA. Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): searching for Standards. J Pain Symptom Manage 2010;39: 1077-85
4. Stiefel F, Barth J, Bensing J, et al. Communication skills training in oncology: a position paper based on a consensus meeting among European experts in 2009. Ann Oncol 2010;21:204-7.
5. Neuss MN, Desch CE, McNiff KK, et al. A Process for Measuring the Quality of Cancer Care: the Quality Oncology Practice Initiative. J Clin Oncol 2005;23: 6233-9
6. Roila F, Cortesi E. Quality of life as a primary end point in oncology. Ann Oncol 2001;12:S3-6
7. Malik IA, Khan WA, Qazilbash M, et al. Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial. Am J Clin Oncol 1995;18: 170-5
8. Roscoe JA, Morrow GR, Aapro MS, et al. Anticipatory nausea and vomiting. Support Care Cancer 2011;19: 1533-8
9. Coates A, Abraham S, Kaye SB, et al. On the receiving end-patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol 1983;19:203-8
10. Griffin AM, Butow PN, Coates AS, et al. On the receiving end. V: patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol 1996;7:189-95
11. Carelle N, Piotto E, Bellanger A, et al. Changing patient perceptions of the side effects of cancer chemotherapy. Cancer 2002;95:155-63
12. Bosnjak S, Radulović S, Nesković-Konstantinović Z, Mitrović L. Patient statement of satisfaction with antiemetic treatment is related to quality of life. Am J Clin Oncol 2002;23: 575-8
13. Hickok JT, Roscoe JA, Morrow GR, et al. Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treated in the community. Cancer 2003;97: 2880-6
14. Dodd MJ, Miaskowski C, Paul SM. Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 2001;28: 465-70
15. Colbourne L. Patients' experiences of chemotherapy treatment. Prof Nurse 1995;10: 439-42
16. De Boer-Dennert M, De Wit R, Schmitz PI, et al. Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists. Br J Cancer 1997;76: 1055-61
17. Lindley C, McCune JS, Thomason TE, et al. Perception of chemotherapy side effects cancer versus noncancer patients. Cancer Pract 1999;7:59-65
18. Vogel BA, Leonhart R, Helmes AW. Communication matters: the impact of communication and participation in decision making on breast cancer patients' depression and quality of life. Patient Educ Couns 2009;77: 391-7
19. Priestman TJ, Baum M. Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet 1976;1: 899-900
20. Wong RKS, Franssen E, Szumacher E, et al. What do patients living with advanced cancer and their carers want to know? - a needs assessment. Support Care Cancer 2002;10: 408-15
21. Cooper S, Georgiou V. The impact of cytotoxic chemotherapy-perspectives from patients, specialists and nurses. Eur J Cancer 1992;28A(Suppl 1):S36-8
22. Ballatori E, Roila F. Impact of nausea and vomiting on quality of life in cancer patients during chemotherapy. Health Qual Life Outcomes 2003;1:46
23. Gibson RJ, Keefe DMK. Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies. Support Care Cancer 2006;14: 890-900
24. Feld R. Endpoints in cancer clinical trials: is there a need for measuring quality of life? Support Care Cancer 1995;3: 23-7